NCT02929225View on ClinicalTrials.gov

Effectiveness of Probiotics to Treat End Stage Renal Disease

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

January 30, 2018

Study Completion Date

March 30, 2018

Conditions
Kidney Failure, Chronic
Interventions
DRUG

Bifid Triple Viable Capsules

BIFICO is prescribed as a dose of 4 capsules twice daily in half hours after meals.

OTHER

placebo

placebo is also prescribed as a dose of 4 capsules twice daily

Trial Locations (1)

710061

First Affiliated Hospital of Xi'an Jiaotong University, Xi’an

All Listed Sponsors
lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER

NCT02929225 - Effectiveness of Probiotics to Treat End Stage Renal Disease | Biotech Hunter | Biotech Hunter